Elysium Creatine+: A Three-Ingredient Stack Targeting Strength, Recovery, and Longevity
BiohackingElysium Health has launched Creatine+, a three-compound formulation that stacks creatine monohydrate with two muscle-support compounds less commonly found in standalone creatine products: HMB (β-hydroxy β-methylbutyrate) and pomegranate polyphenols sourced as urolithin A precursors. The formulation was developed with input from Michael Fredericson, M.D., co-director of the Stanford Center on Longevity.
Context
Elysium has built its supplement line around the longevity research community — its flagship Basis product targets NAD+ precursor supplementation. Creatine+ follows a similar pattern: take a well-studied base compound (creatine) and layer in additional ingredients with emerging longevity and muscle-preservation research behind them.
The product sits in an increasingly crowded market. Creatine monohydrate is one of the most thoroughly studied ergogenic compounds in sports science, but Elysium’s pitch is differentiation through combination: the additional ingredients are positioned for muscle maintenance in aging populations rather than pure performance optimization.
Standout
The three-ingredient logic is coherent as a longevity formulation. Creatine monohydrate has a robust evidence base for supporting strength, power output, and cognitive function across age groups. HMB — a leucine metabolite — has research supporting its role in reducing muscle protein breakdown, particularly relevant for older adults experiencing sarcopenia-related muscle loss. Pomegranate polyphenols are included as urolithin A precursors; urolithin A has attracted significant research attention for its role in mitophagy and mitochondrial function in aging muscle tissue.
The micronized formulation is a practical detail — finer particle size is associated with better solubility and mixing, a consistent complaint with some creatine products.
Fredericson’s involvement as a Stanford-affiliated longevity researcher lends clinical credibility beyond the typical supplement advisor arrangement.
The Catch
Elysium has not disclosed specific dosages for any of the three compounds in publicly available product materials, per Longevity Technology’s coverage. Without knowing the HMB and urolithin A precursor amounts, it’s not possible to assess whether they reach doses used in the underlying research — a meaningful gap for anyone evaluating this against a DIY stack.
Pricing also hasn’t been widely publicized at launch, and the product appears to be available direct-to-consumer through Elysium Health’s website rather than through major retail channels, which limits comparison shopping.
The So What
Creatine+ is a thoughtful formulation if the ingredient rationale holds at the actual doses. The combination of creatine, HMB, and urolithin A precursors addresses different aspects of muscle physiology — synthesis support, breakdown inhibition, and mitochondrial quality control — in a way that’s more targeted than most “advanced creatine” products on the market. The Stanford connection adds credibility. But until Elysium publishes the dosage breakdown, you’re making a bet on ingredient selection without the full picture. For anyone already exploring longevity-focused supplementation, this is worth watching as more formulation details emerge.
Content created with AI assistance and reviewed for accuracy.
Join the conversation
Stack Insiders is our free community for readers who want to go deeper — share resources, ask questions, and connect with others across every vertical we cover.
Join Stack Insiders →